SEC Form D · filed July 14, 2020
Janux Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (11)
Tighe J. Reardon · La Jolla, CAExecJay J. Lichter, Ph.D · La Jolla, CADirectorStefan J. Heller · La Jolla, CADirectorDavid Campbell, Ph.D · La Jolla, CAExec · DirectorThomas C. Lynch, Jr · WASHINGTON, Washington, D.C.ExecSteve Kurz · New York, NYDirectorChristopher Ferraro · New York, NYDirectorMeltem Amiot-Karakoc · Luxembourg, LuxembourgDirectorKristian Schnittger · Luxembourg, LuxembourgDirectorRichard H. Coats · Midland, TXExecDavid Campbell, Ph.D · La Jolla, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗